NEW YORK, Oct. 18, 2023 /PRNewswire/ — The doxorubicin market is expected to grow by USD 469.97 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 6.07% during the forecast period, according to Technavio Research. The market is segmented by…